Guanhao Biotech Co.,Ltd. (SHE:300238)
China · Delayed Price · Currency is CNY 15.84
+0.87 (5.81%)
Mar 6, 2026, 3:04 PM CST
Guanhao Biotech Market Cap
Guanhao Biotech has a market cap or net worth of 4.2 billion as of March 6, 2026. Its market cap has increased by 26.11% in one year.
Market Cap
4.20B
Enterprise Value
4.10B
Revenue
392.83M
Ranking
n/a
PE Ratio
160.08
Stock Price
15.84
Market Cap Chart
Since July 6, 2011, Guanhao Biotech's market cap has increased from 2.74B to 4.20B, an increase of 53.06%. That is a compound annual growth rate of 2.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.20B | 14.37% |
| Dec 31, 2025 | 3.67B | 15.03% |
| Dec 31, 2024 | 3.19B | -11.21% |
| Dec 29, 2023 | 3.60B | 31.91% |
| Dec 30, 2022 | 2.73B | -44.52% |
| Dec 31, 2021 | 4.91B | -26.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Obio Technology (Shanghai) Corp. | 4.34B |
| Zhejiang Shouxiangu Pharmaceutical | 4.15B |
| Hinova Pharmaceuticals | 4.01B |
| Zhejiang Wecome Pharmaceutical Company | 3.95B |
| Baolingbao Biology | 3.88B |
| Qingdao Vland Biotech INC. | 3.75B |
| Boji Medical Technology | 3.71B |
| Shanghai Shen Lian Biomedical | 3.63B |